The peptide hormones cholecystokinin (CCK) and gastrin are bound by a class of G-protein coupled receptors known as cholecystokinin receptors. Cholecystokinin A receptor (CCK-AR), which is primarily found on pancreatic acinar cells, and CCK-BR, which is primarily found in the stomach and nervous system tissues, have both been identified as the endogenous receptors of CCK. Both have high affinity for gastrin, but only the CCK-BR has high affinity for the sulfated CCK octapeptide (CCK-8).
A peptide hormone called CCK was found in the small intestine. The traditional triad of gut hormones includes secretin, gastrin, and CCK. In addition to controlling gallbladder contraction, CCK also controls intestinal motility, satiety signaling, pancreatic enzyme secretion and growth, and the inhibition of gastric acid secretion. In central and intestinal neurons, CCK also functions as a transceiver.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V12862 | Caerulein (Caerulein; Cerulein; FI-6934) | 17650-98-5 | Caerulein (Caerulein; Cerulein; FI-6934) is a novel, potent and specific decapeptide-based cholecystokinin receptor agonist, it is produced in the skin of Hila caerulea, an Australian amphibian. |
|
V14030 | Loxiglumide | 107097-80-3 | Loxiglumide is a potent, orally bioavailable, and selective CCK-A receptor antagonist which stimulates calorie intake and hunger feelings in humans. |
|
V26248 | Nastorazepide (Z-360) | 209219-38-5 | Nastorazepide, formerly known as Z-360, is a selective, orally bioavailable, 1,5-benzodiazepine-analogue gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity. |
|
V14810 | Sincalide (CCK-8) | 25126-32-3 | Sincalide (CCK-8) is a cholecystokinetic drug used to treat cholecystitis and to diagnose disorders of the gallbladder and pancreas. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
